创新药大牛市继续,最受益也是中国最强的创新药龙头,高瓴资本重仓公司!

萝卜投研
07 Jul

高瓴资本是百济神州的十大股东之一!百济神州2025年第一季度财报显示,公司营业收入达80.5亿元,同比增长50.2%,主要得益于产品收入的增长。经调整后,公司实现营业利润11.71亿元,净利润8.85亿元。研发投入为34.74亿元,占营业收入的比例为43.16%。公司总资产为421亿元,归属于上市公司股东的所有者权益为252亿元。继首季度盈利之后,6 月 26 日,百济神州举行了投资者研发日活动。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10